Abstract
We determined the cardiovascular responses as well as food and water intakes to chronic intracerebroventricular administration of orexin-A and orexin-B for 14 days in conscious rats. Chronic intracerebroventricular infusion of orexin-A (50 pmol/h) elicited a significant increase in systolic blood pressure on the third day (+15.6 +/- 2.9 mm Hg), and during the continuous intracerebroventricular infusion of orexin-A the blood pressure returned to the baseline levels at day 14. In contrast, chronic intracerebroventricular infusion of orexin-B (50 pmol/h) failed to change systolic blood pressure during the 14 days of experimental periods. Chronic intracerebroventricular infusions of neither orexin-A nor orexin-B changed urinary catecholamine excretions, food and water intakes, and urine volumes at 7 and 14 days of infusion periods. Mean arterial pressure directly measured at 14 days did not differ among the groups of orexin-A, orexin-B, and artificial cerebrospinal fluid treatments. Both intravenous injections of pentolinium (5 mg/kg), a ganglion blocking agent, and CV-11974 (0.05 mg/kg), an AT(1) receptor antagonist, decreased arterial pressure; however, these responses were not different among the groups. These results suggest th...Continue Reading
References
Jun 1, 1991·Hypertension·K MatsumuraM Fujishima
Oct 10, 1997·Hypertension·W G HaynesA L Mark
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·L de LeceaJ G Sutcliffe
Feb 7, 1998·Hypertension·E W ShekJ E Hall
Mar 10, 1998·Cell·T SakuraiM Yanagisawa
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y DateM Nakazato
Mar 5, 1999·Brain Research·D C SweetC M Kotz
Mar 9, 1999·Neuron·J K ElmquistC B Saper
May 13, 1999·Brain Research·T NambuK Goto
Sep 28, 1999·Peptides·A C HaynesJ R Arch
Dec 11, 1999·Brain Research·A YamanakaK Goto
Jan 11, 2000·Hypertension·K MatsumuraI Abe
May 1, 2001·Journal of Neuroendocrinology·M JászberényiG Telegdy
Jun 16, 2001·Hypertension·K MatsumuraI Abe
Nov 17, 2001·Hypertension·K MatsumuraI Abe
Citations
Feb 27, 2004·Physiology & Behavior·Robert Di NicolantonioMichal Pravenec
Nov 27, 2002·Neuropeptides·R J RodgersJ E Blundell
Jul 2, 2003·Regulatory Peptides·Kiyoshi MatsumuraMitsuo Iida
May 3, 2003·Neuroscience Research·Shi-Bin ChengShiro Nakagawa
May 11, 2010·The Medical Clinics of North America·Michelle Cao
Oct 4, 2007·Frontiers in Neuroendocrinology·Kousaku Ohno, Takeshi Sakurai
Nov 17, 2004·Regulatory Peptides·Jon J RamseyAndrew G Swick
Sep 10, 2005·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Beng Ti AngIvan Ng
Aug 6, 2013·Neuroscience·J CirielloE B Bruckschwaiger
Sep 28, 2013·Neuroscience·J CirielloZ Li
May 17, 2014·Frontiers in Neuroscience·Miles D ThompsonJyrki P Kukkonen
Jul 28, 2016·Molecular and Cellular Endocrinology·B MikuláškováJ Kuneš
May 17, 2017·Naunyn-Schmiedeberg's Archives of Pharmacology·Monika RaniPawan Krishan
Nov 10, 2006·Journal of Psychopharmacology·R H HouC M Bradshaw
Oct 28, 2016·Journal of Basic and Clinical Physiology and Pharmacology·Giovanni MessinaMarcellino Monda
Mar 30, 2017·Current Hypertension Reports·Roberta ImperatoreLuigia Cristino
Jan 8, 2021·Brain Research·Burcin AltinbasMurat Yalcin